American Hospital Association April 18, 2024

The Department of Health and Human Services April 18 finalized its rule to establish a 340B Administrative Dispute Resolution process as required under the Affordable Care Act. The rule establishes an ADR process that allows all 340B covered entities, regardless of the size of the organization or monetary value of the claim, to avail themselves of this important process to address claims at dispute with drug companies.

Specifically, the new finalized ADR process would:

  • Create a more conventional administrative process that is less trial-like consisting of 340B program subject matter experts from the Health Resources and Services Administration’s Office of Pharmacy Affairs.
  • Allow covered entities to bring forth claims where they have been overcharged by a drug company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACA (Affordable Care Act), Govt Agencies, Health System / Hospital, HHS, Insurance, Provider
New York’s 1332 Waiver Extends Affordable Coverage to Additional Groups
HHS' final rule to combat disability discrimination: What healthcare leaders should know
HHS Finalizes Antidiscrimination Rules On Patient Care Decision Tools, Including AI
Medical research is changing, data privacy laws have not
J&J,, BMS set to appeal losses in IRA drug pricing lawsuits

Share This Article